Rivastigmine for Alzheimer's disease
31 results
1 - 31
Rivastigmine for Alzheimer's disease
Rivastigmine for Alzheimer’s disease - Cholinesterase inhibitors for Alzheimer's disease
- Galantamine for Alzheimer’s disease
- Rivastigmine for vascular cognitive impairment
- Rivastigmine for dementia in people with Down syndrome
- Cholinesterase inhibitors for Parkinson's disease dementia
- Alzheimer’s disease
Cognitive enhancers significantly improve Mini-Mental State Examination score in patients with Alzheimer's dementia- Treatment of a patient with memory disease
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
- Dementia treatments minimally effective
- Parkinson's disease dementia and dementia with Lewy bodies
- Cholinesterase inhibitors for Alzheimer’s disease
- Some drugs slightly improve cognition in people with dementia; effects on behavioral or psychological symptoms remain unclear
- Cholinergic medication for antipsychotic‐induced tardive dyskinesia
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Pharmacological interventions for the treatment of delirium in critically ill adults
- Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
- Pharmacological interventions for cognitive decline in people with Down syndrome
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review